Health and Medicine
-
February 17, 2022
Pandemic leads to broader use of monoclonal antibodies
Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19. -
February 15, 2022
Predicting brain cancer outcome
Red blood cell distribution width has prognostic value for many diseases, but it was not associated with overall survival in patients with glioblastoma, Vanderbilt researchers found. -
February 10, 2022
Diverticulitis surgery: guidelines needed
Surgical removal of the colon for recurrent diverticulosis varies by geographic region and is associated with surgeon and hospital factors; stronger national guidelines are needed, Vanderbilt researchers report. -
February 10, 2022
New insights into hypothalamic obesity
A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report. -
February 9, 2022
Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization
Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. -
February 2, 2022
VUMC study raises hope for improving treatment of kidney disease
Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure. -
February 2, 2022
VUMC’s Knollman, Ware among new AAAS Fellows
Vanderbilt's Ware, Knollman among new American Association for the Advancement of Science Fellows.